GPX4 and hepatocellular carcinoma: It has the potential to induce ferroptosis in colorectal cancer and hepatocellular carcinoma by elevating the levels of ROS and SOD, while downregulating GPX4, GSH, and IGF2BP3 [18,19,20,23,25].